Biological markers for diagnosis of Alzheimer's disease
Takeda, M.; Tanaka, T.; Kudo, T.; Okochi, M.; Kamino, A.; Tagami, S.
Seishin Shinkeigaku Zasshi 106(12): 1610-1614
2004
ISSN/ISBN: 0033-2658 PMID: 15770965 Document Number: 568721
Document emailed within 1 workday
Related Documents
Kurz, A.; Riemenschneider, M.; Drzezga, A.; Lautenschlager, N. 2002: The role of biological markers in the early and differential diagnosis of Alzheimer's disease Journal of Neural Transmission. Supplementum 2002(62): 127-133Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Green, R.C.; Clarke, V.C.; Thompson, N.J.; Woodard, J.L.; Letz, R. 1997: Early detection of Alzheimer disease: methods, markers, and misgivings Alzheimer Disease and Associated Disorders 11(Suppl): S1
Braginskaia, F.I.; Zorina, O.M.; Pal'mina, N.P.; Gaintseva, V.D.; Burlakova, E.B.; Selezneva, N.D.; Kolykhalov, I.V.; Gavrilova, S.I. 2000: Certain biochemical blood markers in the process of cholinergic therapy in Alzheimer's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(6): 29-32
Friedland, R.P.; Koss, E.; Haxby, J.V.; Grady, C.L.; Luxenberg, J.; Schapiro, M.B.; Kaye, J. 1988: NIH conference. Alzheimer disease: clinical and biological heterogeneity Annals of Internal Medicine 109(4): 298-311
Nizamutdinov, I.I.; Andreeva, T.V.; Stepanov, V.A.; Marusin, A.V.; Rogaev, E.I.; Zasedatelev, A.S.; Nasedkina, T.V. 2013: Biochip for determination of genetic markers of sporadic Alzheimer's disease in the Russian Slavic population Molekuliarnaia Biologiia 47(6): 949-958
Rosales-Reynoso, M.ón.A.; Ochoa-Hernández, A.B.; Juárez-Vázquez, C.I.; Barros-Núñez, P. 2012: Alzheimer's disease and fragile X syndrome: the Wnt/ß-catenin pathway as a common biological mechanism Revista de Neurologia 55(9): 543-548
Ruddon, R.W.; Norton, S.E. 1993: Use of biological markers in the diagnosis of cancers of unknown primary tumor Seminars in Oncology 20(3): 251-260
Meunier, P.J.; Salson, C.; Delmas, P.D. 1989: Skeletal distribution and biological markers of Paget's disease La Revue du Praticien 39(13): 1125-1128
Buravlev, V.M.; Pavlova, E.V.; Vostrikov, V.M. 1986: Effect of biological fluids and brain extracts of persons with Alzheimer's disease on nerve tissue cultures Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 86(7): 1007-1011
Sánchez Lombraña, J.; Palacio, M.A.; Carbajal, C.; Vivas, S.; Pérez, R.; Rodrigo, L. 1997: Biological markers of activity in chronic inflammatory bowel disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 89(11): 855-858
Kojima, T. 2006: Present status and future aspects of biological markers for diagnosis of mental disorders Seishin Shinkeigaku Zasshi 108(6): 631-632
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Coll, P.P.; Fortinsky, R.H.; Kaplan, R.; Song, C. 2003: Diagnosis and management of Alzheimer's disease Connecticut Medicine 67(8): 505-510
Hasan, M.K.; Slack, N.L.; Mooney, R.P. 1983: Diagnosis and treatment of Alzheimer's disease West Virginia Medical Journal 79(5): 98-102